charitha13

Dr,  Freelancer 

Location: India

Consulting Services


Areas Of Interest

Cancer Clinical Research Protocol Grants Peer Review

Professional Narrative

I am a cell biologist by training later moved on to work as a clinical researcher.  I have the coordinated several biological specimen related clinical studies (national and international), and  the Regulatory approvals (IRB, HMSC, CTRI). I have the expertise in protocol writing, consent from development, case report generation. In addition i have worked on writing grants. Being involved in different clinical trials (drugs/ devices) i have gained knowledge on the site level activities of clinical trials .


Employment


Education

PhD, CDFD 2010

Referees


Publications

Singh, A., Bhat, V., Sudhakar, S., Namachivayam, A., Gangadharan, C., Pulchan, C., & Sigamani, A. (2021).
Multicentric study to evaluate the effectiveness of Thermalytix as compared with standard screening modalities
in subjects who show possible symptoms of suspected breast cancer. BMJ open, 11(10), e052098.
• Gangadharan, Charitha, Rupa Ahluwalia, and Alben Sigamani. "Diabetes and COVID-19: Role of insulin resistance
as a risk factor for COVID-19 severity." World Journal of Diabetes 12.9 (2021): 1550.
• Gangadharan C, Wills S, Vangala RK, Sigamani A. Biobanking for Translational Diabetes Research in India. Biores
Open Access. 2020;9(1):183-189. Published 2020 Aug 19. doi:10.1089/biores.2019.0052
• Charitha Gangadharan, Alben Sigamani, Mohammed Rahmatullah. Phytotherapeutic approaches to
manage/treat obesity. World Journal of Pharmaceutical medical Research, 2020,6(6), 04-19
• Gangadharan C, Nataraj KS, Majumder S, Sigamani A (2019) Minimal Residual Disease in ALL: Clinical challenges
and Indian perspective. J Mol Cell Biochem Vol.3 No.1:1
• Prabhu JS, Kaul R, Korlimarla A, Desai K, Gangadharan C, Rajarajan S, Nair MG, Alexander A, Kaluve R, Manjunath
S, Correa M, Prasad MSN, Patil S, Srinath BS, Sridhar TS. Epithelial mesenchymal transition associated with high
miR-221 and integrin β6 leads to poor prognosis in hormone receptor positive HER2 negative breast cancers
[abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX.
Philadelphia (PA): AACR; Cancer Res 2017; 77(4 Suppl): Abstract nr P4-07-10.
• Naik, U.S., Gangadharan, C., Abbagani, K., Nagalla, B., Dasari, N., and Manna, S.K. (2011): A study of nuclear
transcription factor kappaB in childhood autism. Plos One 6: e19488.
• Manna S.K. and Gangadharan, C. (2009): Decrease in RelA phosphorylation by inhibiting protein kinase A induces
cell death in NF-kappaB-expressing and drug-resistant tumor cells. Molecular Immunology 46: 1340-1350.


Grants,Awards and Certifications

Grants :

.

Awards & Prizes :

Participant in “The Swedish Institute Expert Visitors’ Program 2019- Life Sciences
• Received first prize for poster presentation held in the International conference - evidence based medicine &
clinical research conference (EBCCON 2020)
• Recipient of iCare Award H1 of 2017-18
• Dr. KV Rao Young Scientist Award, 2010
• Recipient of CSIR Travel Grant, 2010
• Recipient of Travel Grant from G P Talwar Immunological Foundation,2010
• Qualified for Junior & Senior Research Fellowship and contingency grant (2005-2010) from UGC-CSIR-NET,
Government of India.
• Qualified GATE in Life science, 2005
• Recipient of National Merit Scholarship (2002-2004)
• Recipient of several awards in B.Sc. examination 2002
✓ The Lady Mirza prize.
✓ The Alamelammal H Ramanuja Iyengar Gold medal
✓ Annapoorna Kamath Memorial Award (B. Sc. Biochemistry)
✓ Mysore Viswavidyanilaya Hindi Reader Sachidananda Swarna Padak (Hindi)
✓ 6
th Rank in the university B. Sc. Examination held in 2002


Languages

Language Proficiency :

English (Excellent Spoken and Written)

Translation Services :

Malayalam to English (Excellent Spoken and Written) to English (Excellent Spoken and Written) Hindi (Sanskritised Hindustani) to English (Excellent Spoken and Written) to English (Excellent Spoken and Written)